YQB-50816-32375
3 vaccinations
2 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 991 / WA
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Pfizer-BioNTech
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
-
2021-02-06
Dose 2 — Pfizer-BioNTech
-
2021-02-06
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, NauseaAdult check-in
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-05-08
- 2021-08-07
-
2022-02-06
Survey response — 12 months, dose 2MedDRA: COVID-19, Hepatomegaly, Liver disorder, Office visit, Tachycardia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: COVID-19 (Delta) Inappropriate tachycardia Hepatomegaly & liver dysfunction · Healthcare visit (other): Dr appts, bloodwork, GI specialistMedDRA releases: 2024-11 · check-in free text available
-
2022-02-06
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-31
-
2022-07-07
Dose 3 — Pfizer-BioNTech
-
2022-10-08
Survey response — 3 months, dose 3MedDRA: Pulmonary congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Lung congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-08
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-10
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Pfizer-BioNTech | |
| 2 | 2021-02-06 | Pfizer-BioNTech | |
| 3 | 2022-07-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-06 | Unsuccessful | |
| 2022-10-08 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: COVID-19 (Delta) Inappropriate tachycardia Hepatomegaly & liver dysfunction
Healthcare visit (other): Dr appts, bloodwork, GI specialist
Release 12 — 3 months, dose 3
Symptoms: Lung congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hepatomegaly | · | · | ✓ |
| SD | Liver disorder | · | · | ✓ |
| SD | Pulmonary congestion | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release